Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1-phosphate

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 12, 2010, Pages 2631-2638

  Pula, Giordano ^a   Garonna, Elena ^a   Dunn, Warwick B ^b   Hirano, Michio ^c   Pizzorno, Giuseppe ^d   Campanella, Michelangelo ^a,g   Schwartz, Edward L ^e   El Kouni, Mahmoud H ^f   Wheeler Jones, Caroline P D ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NewYork Presbyterian Hospital   (United States)

^d NEVADA CANCER INSTITUTE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f University of Alabama at Birmingham   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

angiogenesis; deoxyribose 1 phosphate; endothelium; platelets; reactive oxygen species

Indexed keywords

BETA3 INTEGRIN; DEOXYRIBOSE 1 PHOSPHATE; REACTIVE OXYGEN METABOLITE; RIBOSE PHOSPHATE; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG; URIDINE PHOSPHORYLASE; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ANIMALS; BLOOD PLATELETS; CELL MOVEMENT; CELLS, CULTURED; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL CELLS; ENZYME INHIBITORS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE SILENCING; HUMANS; INTEGRIN ALPHAV; INTEGRIN ALPHAVBETA3; INTEGRIN BETA3; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; REACTIVE OXYGEN SPECIES; RIBOSEMONOPHOSPHATES; THROMBIN; THYMIDINE PHOSPHORYLASE; TIME FACTORS; URIDINE PHOSPHORYLASE;

EID: 78650420402     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.215855     Document Type: Article

References (36)

1. Brill A, Elinav H, Varon D. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res. 2004;63:226-235.
2. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived micro-particles induce angiogenesis and stimulate post-ischemic revasculariza-tion. Cardiovasc Res. 2005;67:30-38.
3. Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, Preissner KT. The functional role of blood platelet components in angio-genesis. Thromb Haemost. 2004;92:394-402.
4. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532-3548.
5. Langer HF, Gawaz M. Platelets in regenerative medicine. Basic Res Cardiol. 2008;103:299-307.
6. Pintucci G, Froum S, Pinnell J, Mignatti P, Rafii S, Green D. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb Haemost. 2002;88:834-842.
7. Thommen R, Humar R, Misevic G, Pepper MS, Hahn AW, John M, Battegay EJ. PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J Cell Biochem. 1997;64: 403-413.
8. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N. Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem. 2004;279:23536-23541.
9. Pi X, Wu Y, Ferguson JE, III, Portbury AL, Patterson C. SDF-1a stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration. Proc Natl Acad Sci USA. 2009;106: 5675-5680.
10. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohln-hoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M, Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, Gawaz M. Platelets secrete stromal cell-derived factor 1 a and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006; 203:1221-1233.
11. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schonberger T, Pfisterer I, Hatzopoulos AK, Gawaz M. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006;98:e2-e10.
12. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 2000;14:2255-2265.
13. Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res. 2007;100:782-794.
14. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, Akiyama S. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/ thymidine phosphorylase. Cancer Res. 1995;55:1687-1690.
15. Sengupta S, Sellers LA, Matheson HB, Fan TP. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol. 2003;139:219-231.
16. Hotchkiss KA, Ashton AW, Klein RS, Lenzi ML, Zhu GH, Schwartz EL. Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res. 2003;63:527-533.
17. Tozzi MG, Camici M, Mascia L, Sgarrella F, Ipata PL. Pentose phosphates in nucleoside interconversion and catabolism. FEBS J. 2006;273: 1089-1101.
18. Lopez LC, Akman HO, Garcia-Cazorla A, Dorado B, Marti R, Nishino I, Tadesse S, Pizzorno G, Shungu D, Bonilla E, Tanji K, Hirano M. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet. 2009;18: 714-722.
19. Pula G, Crosby D, Baker J, Poole AW. Functional interaction of protein kinase Ca with the tyrosine kinases Syk and Src in human platelets. J Biol Chem. 2005;280:7194-7205.
20. Campanella M, Seraphim A, Abeti R, Casswell E, Echave P, Duchen MR. IF1, the endogenous regulator of the F(1)F(o)-ATPsynthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagy. Biochim Biophys Acta. 2009;1787:393-401.
21. Klein RS, Lenzi M, Lim TH, Hotchkiss KA, Wilson P, Schwartz EL. Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase. Biochem Pharmacol. 2001;62:1257-1263.
22. el Kouni MH, Goudgaon NM, Rafeeq M, Al Safarjalani ON, Schinazi RF, Naguib FN. 5-phenylthioacyclouridine: a potent and specific inhibitor of uridine phosphorylase. Biochem Pharmacol. 2000;60:851-856.
23. Pula G, Mayr U, Evans C, Prokopi M, Vara DS, Yin X, Astroulakis Z, Xiao Q, Hill J, Xu Q, Mayr M. Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures. Circ Res. 2009; 104:32-40.
24. Han Z, Varadharaj S, Giedt RJ, Zweier JL, Szeto HH, Alevriadou BR. Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cells. J Pharmacol Exp Ther. 2009;329:94-101.
25. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987;262:17703-17711.
26. Ribatti D. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol. 2008;270:181-224.
27. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of av/33 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 1999;18:882-892.
28. Hotchkiss KA, Ashton AW, Schwartz EL. Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins 5/31 and aV/33. J Biol Chem. 2003;278: 19272-19279.
29. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, Plow EF. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell. 2000;6:851-860.
30. Herouy Y, Mellios P, Bandemir E, Stetter C, Dichmann S, Idzko M, Hofmann C, Vanscheidt W, Schopf E, Norgauer J. Autologous platelet-derived wound healing factor promotes angiogenesis via av/33-integrin expression in chronic wounds. Int J Mol Med. 2000;6:515-519.
31. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res. 2000;60:6298-6302.
32. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 1989;338:557-562.
33. Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J. 1998;334:1-8.
34. Uchimiya H, Furukawa T, Okamoto M, Nakajima Y, Matsushita S, Ikeda R, Gotanda T, Haraguchi M, Sumizawa T, Ono M, Kuwano M, Kanzaki T, Akiyama S. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose. Cancer Res. 2002;62: 2834-2839.
35. Liekens S, Hernandez AI, Ribatti D, De Clercq E, Camarasa MJ, Perez-Perez MJ, Balzarini J. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action. J Biol Chem. 2004;279: 29598-29605.
36. Matsushita S, Nitanda T, Furukawa T, Sumizawa T, Tani A, Nishimoto K, Akiba S, Miyadera K, Fukushima M, Yamada Y, Yoshida H, Kanzaki T, Akiyama S. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res. 1999;59:1911-1916.